Search & Filter

This week's World Stroke Day used the theme is 'I am woman' to highlight the fact that women are not only at higher risk of stroke, but are also more likely to die from the condition compared to men.

A comprehensive new resource to support health and social care staff and educators who work with people living with dementia and their carers has been launched.

The European Medicines Agency (EMA) has recommended authorising talimogene laherparepvec (Imlygic) for the treatment of adults with melanoma that cannot be removed by surgery and that has spread either to the surrounding area or to other areas of the body without affecting the bones, brain, lung or other internal organs.

NICE has issued final guidance supporting the use of tolvaptan (Jinarc) for the treatment of autosomal dominant polycystic kidney disease (ADPKD).

Traditional societies may see the ageing process in a more positive light than modern societies, according to a Cornell researcher in a recent study published in the Journals of Gerontology: Psychological Science.

Cancer Research UK-funded scientists have developed a blood test that could help pair cancer patients with the most suitable therapy for their disease and then track the tumour's progress to see if the treatment is working, according to research published in Clinical Cancer Research.

Infections such as typhoid, measles and tuberculosis have been linked with an increased risk of early heart attacks, a study of the Indonesia population presented at the Acute Cardiovascular Care conference has revealed.

Ocrelizumab has become the first drug treatment to show positive results in primary progressive multiple sclerosis (MS) following phase 3 clinical studies. Previously, all phase 3 studies with MS medication have been negative.

Further strides need to be made to reduce the mortality associated with venous thromboembolism (VTE) and arterial thrombosis caused atrial fibrillation (AF) despite the increased awareness generated by World Thrombosis Day according to its organisers.

Immune cells are more active in the brains of people at risk of schizophrenia as well as those already diagnosed with the condition, a new study has found.

Antipsychotic drugs are initiated in patients with Alzheimer's disease (AD) more frequently than in the general population €“ already 2€“3 years before the Alzheimer's diagnosis, according to a new study from the University of Eastern Finland.

Patients in Scotland with an advanced and incurable form of gastric cancer (stomach and gastro-oesophageal) could benefit from the life-extending treatment Herceptin, which has been given the green light by the Scottish Medicines Consortium (SMC) for routine use on the NHS.

Nutricia has launched a free, tailored support programme that offers carers and people with mild Alzheimer's disease who are taking Souvenaid, practical advice and skills to help them address the challenges they may experience.

Diabetes UK and Novo Nordisk are delighted to announce the appointment of 20 Diabetes UK Clinical Champions who will be supported and empowered in their workplace to transform care for people living with diabetes.

Functional magnetic resonance imaging (fMRI) could be used to predict which patients who have recovered from major depressive disorder are most likely to go on to have more depressive episodes, according to a new study.